Literature DB >> 31738906

Novel indol-3-yl-thiosemicarbazone derivatives: Obtaining, evaluation of in vitro leishmanicidal activity and ultrastructural studies.

Paula Roberta da Silva1, Jamerson Ferreira de Oliveira1, Anekécia Lauro da Silva2, Camila Marques Queiroz3, Ana Paula Sampaio Feitosa3, Denise Maria Figueiredo Araújo Duarte1, Aline Caroline da Silva4, Maria Carolina Accioly Brelaz de Castro5, Valéria Rêgo Alves Pereira4, Rosali Maria Ferreira da Silva6, Luiz Carlos Alves3, Fábio André Brayner Dos Santos3, Maria do Carmo Alves de Lima7.   

Abstract

Parasitic diseases still represent serious public health problems, since the high and steady emergence of resistant strains is evident. Because parasitic infections are distributed predominantly in developing countries, less toxic, more efficient, safer and more accessible drugs have become desirable in the treatment of the infected population. This is the case of leishmaniasis, an infectious disease caused by a protozoan of the genus Leishmania sp., responsible for triggering pathological processes from the simplest to the most severe forms leading to high rates of morbidity and mortality throughout the world. In the search for new leishmanicidal drugs, the thiosemicarbazones and the indole fragments have been identified as promising structures for leishmanicidal activity. The present study proposes the synthesis and structural characterization of new indole-thiosemicarbazone derivatives (2a-j), in addition to performing in vitro evaluations through cytotoxicity assays using macrophages (J774) activity against forms of Leishmania infantum and Leishmania amazonensis promastigote as well as ultrastructural analyzes in promastigotes of L. infantum. Results show that the indole-thiosemicarbazone derivatives were obtained with yield values varying from 32.09 to 94.64%. In the evaluation of cytotoxicity, the indole-thiosemicarbazone compounds presented CC50 values between 53.23 and 357.97 μM. Concerning the evaluation against L. amazonensis promastigote forms, IC50 values ranged between 12.31 and  > 481.52 μM, while the activity against L. infantum promastigotes obtained IC50 values between 4.36 and 23.35 μM. The compounds 2d and 2i tested against L. infantum were the most promising in the series, as they showed the lowest IC50 values: 5.60 and 4.36 respectively. The parasites treated with the compounds 2d and 2i showed several structural alterations, such as shrinkage of the cell body, shortening and loss of the flagellum, intense mitochondrial swelling and vacuolization of the cytoplasm leading the parasite to cellular unviability. Therefore, the indole-thiosemicarbazone compounds are promising because they yield considerable synthesis, have low cytotoxicity to mammalian cells and act as leishmanicidal agents.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Indole derivatives; Leishmania amazonensis; Leishmania infantum; Thiosemicarbazone; Ultrastructural studies

Mesh:

Substances:

Year:  2019        PMID: 31738906     DOI: 10.1016/j.cbi.2019.108899

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  3 in total

1.  In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches.

Authors:  Lina S Prieto Cárdenas; Karen A Arias Soler; Diana L Nossa González; Wilson E Rozo Núñez; Agobardo Cárdenas-Chaparro; Pablo R Duchowicz; Jovanny A Gómez Castaño
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-31

2.  Anti-inflammatory activity of novel thiosemicarbazone compounds indole-based as COX inhibitors.

Authors:  Íris T T Jacob; Fabiana O S Gomes; Mirelly D S de Miranda; Sinara M V de Almeida; Iranildo J da Cruz-Filho; Christina A Peixoto; Teresinha G da Silva; Diogo R M Moreira; Cristiane M L de Melo; Jamerson F de Oliveira; Maria C A de Lima
Journal:  Pharmacol Rep       Date:  2021-02-15       Impact factor: 3.024

Review 3.  Recent Progress in the Development of Indole-Based Compounds Active against Malaria, Trypanosomiasis and Leishmaniasis.

Authors:  Paulo A F Pacheco; Maria M M Santos
Journal:  Molecules       Date:  2022-01-05       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.